US 8653107
Fentanyl composition for nasal administration
granted A61KA61K31/435A61K31/4468
Quick answer
US patent 8653107 (Fentanyl composition for nasal administration) held by Takeda Pharma A/S expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharma A/S
- Grant date
- Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/435, A61K31/4468, A61K47/10, A61K47/22